{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,24]],"date-time":"2026-06-24T11:38:10Z","timestamp":1782301090303,"version":"3.54.5"},"reference-count":18,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/j.jiac.2016.12.010","type":"journal-article","created":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T22:18:19Z","timestamp":1484173099000},"page":"214-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in\u00a0epididymal tissue"],"prefix":"10.1016","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5685-3000","authenticated-orcid":false,"given":"Takuya","family":"Sadahira","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuro","family":"Ikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Kurahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Yoshioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Ariyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuyuki","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Motoo","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayano","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masami","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyohiko","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasutomo","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2016.12.010_bib1","first-page":"1203","article-title":"Epididymitis. a 21-year retrospective review of presentations to an outpatient urology clinic","volume":"192","author":"Redshaw","year":"2014","journal-title":"J\u00a0Urol"},{"key":"10.1016\/j.jiac.2016.12.010_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1093\/jac\/30.2.197","article-title":"Disposition of roxithromycin in the epididymis after repeated oral administration","volume":"30","author":"Costa","year":"1992","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib3","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.eururo.2014.12.005","article-title":"Acute epididymitis revisited: impact of molecular diagnostics on etiology and contemporary guideline recommendations","volume":"68","author":"Pilatz","year":"2015","journal-title":"Eur Urol"},{"key":"10.1016\/j.jiac.2016.12.010_bib4","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jiac.2016.04.004","article-title":"Clinical analysis of bacterial strain profiles isolated from urinary tract infections: a 30-year study","volume":"22","author":"Wada","year":"2016","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib5","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/bmc.851","article-title":"A\u00a0rapid and simple high-performance liquid chromatography method for the determination of human plasma levofloxacin concentration and its application to bioequivalence studies","volume":"21","author":"Zhou","year":"2007","journal-title":"Biomed Chromatogr"},{"key":"10.1016\/j.jiac.2016.12.010_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0378-4347(94)00319-X","article-title":"High-performance liquid chromatographic determination of the new quinolone antibacterial agent DU-6859a in human serum and urine using solid-phase extraction with photolysis-fluorescence detection","volume":"660","author":"Aoki","year":"1994","journal-title":"J\u00a0Chromatogr B Biomed Appl"},{"key":"10.1016\/j.jiac.2016.12.010_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1248\/bpb1978.4.879","article-title":"A\u00a0pharmacokinetic analysis program (multi) for microcomputer","volume":"4","author":"Yamaoka","year":"1981","journal-title":"J\u00a0Pharmacobiodyn"},{"key":"10.1016\/j.jiac.2016.12.010_bib8","first-page":"406","article-title":"Investigation for penetration of single-dose levofloxacin 500 mg in prostate tissue","volume":"63","author":"Sadahira","year":"2015","journal-title":"Jpn J Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1128\/AAC.39.1.170","article-title":"Pharmacokinetics and tolerance of DU-6859a, a new fluoroquinolone, after single and multiple oral doses in healthy volunteers","volume":"39","author":"Nakashima","year":"1995","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/jac\/43.suppl_2.83","article-title":"Pharmacokinetics and elimination of moxifloxacin after oral and intravenous administration in man","volume":"43","author":"Stass","year":"1999","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s101560200000","article-title":"Pharmacokinetics and safety assessment of tosufloxacin tosilate","volume":"8","author":"Niki","year":"2002","journal-title":"J\u00a0Infect Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00228-011-1095-3","article-title":"Optimal dose finding of garenoxacin based on population pharmacokinetics\/pharmacodynamics and Monte Carlo simulation","volume":"68","author":"Tanigawara","year":"2012","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jiac.2016.12.010_bib13","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1093\/jac\/27.3.392","article-title":"Norfloxacin concentrations in plasma and human epididymal tissue after repeated administration","volume":"27","author":"Blondin","year":"1991","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib14","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.urology.2016.05.018","article-title":"Evaluation of adult scrotum in the emergency room: clinical characteristics, diagnosis, management, and costs","volume":"94","author":"Lorenzo","year":"2016","journal-title":"Urology"},{"key":"10.1016\/j.jiac.2016.12.010_bib15","series-title":"The JAID\/JSC guide to clinical management of infectious diseases 2014: XI urogenital infections","first-page":"203","year":"2014"},{"key":"10.1016\/j.jiac.2016.12.010_bib16","first-page":"287","article-title":"Pharmacokinetics and pharmacodynamic target attainment of intravenous pazufloxacin in the bile of patients undergoing biliary pancreatic surgery","volume":"26","author":"Uegami","year":"2014","journal-title":"J\u00a0Chemother"},{"key":"10.1016\/j.jiac.2016.12.010_bib17","series-title":"Performance standards for antimicrobial susceptibility testing: 24th informational supplement","author":"CLSI","year":"2014"},{"key":"10.1016\/j.jiac.2016.12.010_bib18","first-page":"780","article-title":"Bacterial epididymitis in the rat: a model for assessing the impact of acute inflammation on epididymal antibiotic penetration","volume":"144","author":"See","year":"1990","journal-title":"J\u00a0Urol"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16302768?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X16302768?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T18:55:57Z","timestamp":1761159357000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X16302768"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4]]},"references-count":18,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S1341321X16302768"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2016.12.010","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in\u00a0epididymal tissue","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2016.12.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}